Drug Shortage Report for ACTIVASE RT-PA

Last updated on 2025-02-06 History
Report ID 243681
Drug Identification Number 02147440
Brand name ACTIVASE RT-PA
Common or Proper name ALTEPLASE
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) WATER ALTEPLASE
Strength(s) 100ML 100MG
Dosage form(s) POWDER FOR SOLUTION LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1x 100MG VIAL
ATC code B01AD
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-02-17
Actual start date
Estimated end date 2025-07-14
Actual end date
Shortage status Anticipated shortage
Updated date 2025-02-06
Company comments We regret to inform you that Roche Canada is experiencing supply constraints for Activase 100 mg. As a result, we will be out of stock for Activase 100 mg starting mid-February, with resupply expected around mid-year in July. Please note that this shortage does not impact the supply of Activase 50 mg, which will continue to be available. If you require urgent assistance regarding supply please contact Order and Distribution Management: mississauga.order_mgmt@roche.com or through the CPDN portal.
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2025-02-06 French Compare
v13 2025-02-06 English Compare
v12 2025-02-04 French Compare
v11 2025-02-04 English Compare
v10 2025-02-04 English Compare
v9 2025-01-20 French Compare
v8 2025-01-20 English Compare
v7 2025-01-08 French Compare
v6 2025-01-08 English Compare
v5 2025-01-08 French Compare
v4 2024-12-17 French Compare
v3 2024-12-17 English Compare
v2 2024-11-22 French Compare
v1 2024-11-22 English Compare

Showing 1 to 14 of 14